Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-715P is a pseudogene derived from U6 small nuclear RNA (snRNA), a highly conserved non-coding RNA involved in the excision of introns from pre-mRNA as a core part of the spliceosome complex[3]. U6 snRNA and its true gene family members are crucial for post-transcriptional splicing in eukaryotes[3][5]. Pseudogenes such as RNU6-715P are non-functional copies and do not encode functional RNA or protein products, nor do they contribute to splicing or other direct biological processes[4]. The presence of U6 snRNA pseudogenes reflects genomic events where fragments or full copies of non-coding RNAs are inserted into the genome, often as a result of retrotransposition or related molecular mechanisms[1]. While functional U6 snRNA is critical for spliceosome activity, its pseudogenes generally serve only as genomic markers with no established therapeutic or diagnostic utility[3][4].
None applicable (no drugs directly target pseudogenes)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 715, pseudogene (RNU6-715P).